Plasma levels of eicosanoids after transfusion of intraoperatively salvaged blood

Vox Sanguinis

Volumn 78, Issue 1, 2000, Pages 31-36

  Jacobi, K ^a,c   Walther, A ^a   Lorler H ^a   Neidhardt, B ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ICOSANOID; PROSTAGLANDIN E2; THROMBOXANE B2;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; BLOOD AUTOTRANSFUSION; CLINICAL ARTICLE; ERYTHROCYTE; FATTY ACID BLOOD LEVEL; HUMAN; IMMUNE RESPONSE; PRIORITY JOURNAL; PROSTATECTOMY;

EID: 0034056022     PISSN: 00429007     EISSN: None     Source Type: Journal    
DOI: 10.1159/000031146     Document Type: Article

References (30)

1. Gürtler L, Schramm W: Infektionsgefährdung durch Blut oder Blutbestandteile. Dtsch Med Wochensch 1993;118:520-522.
2. Horowitz B, Bonomo R, Prince AM, Chin SN, Brotman B, Shulman RW: Solvent/detergent-treated plasma: A virus-inactivated substitute for fresh frozen plasma. Blood 1992;79: 826-831.
3. Weippert M, Kretschmer V, Roewer J: Die präoperative autologe Blut-und Plasmaspende. Anaesthesiol Reanim 1991;16:305-315.
4. Leikola J: Transfusion transmitted infectious agents, excluding hepatitis and human immunodeficiency viruses. Acta Anaesthesiol Scand 1988;32:20-25.
5. Heiss MM, Delanoff C: Immunmodulatorische Wirkung der Bluttransfusion und Einfluß auf Infektionsrate und Tumorrezidiv. Infusionsther Transfusionsmed 1997;24:20-31.
6. Addonizio VP, Smith JB, Guiod LR, Strauss JF, Colman RW, Edmunds LH: Thromboxane synthesis and platelet protein release during simulated extracorporeal circulation. Blood 1979;54:371-376.
7. Okada M, Kodama T, Tominaga A, Kon K, Sagawa T, Utsiumi S: Cytotoxicity of activated platelets to autologous red blood cells. Br J Haematol 1992;82:142-150.
8. Sieunarine K, Lawrence-Brown MM, Goodman MA, Prendergast FJ, Rocchetta S: Plasma levels of the lipid mediators, leukotriene B4 and lyso platelet-activating factor, in intraoperative salvaged blood. Vox Sang 1992;63:168-171.
9. Bull MH, Bull BS, van Arsdell GS, Smith LL: Clinical implications of procoagulant and leukoattractant formation during intraopertive blood salvage. Arch Surg 1988;123:1073-1078.
10. Bull BS, Bull MH: Enhancing the safety of intraoperative RBC salvage. J Trauma 1989;29: 320-325.
11. Sieunarine K, Langton S, Lawrence-Brown MMD, Goodman MA, Prendergast FJ, Hellings M: Elaslase levels in salvaged blood and the effect of cell washing. Aust NZ J Surg 1990;60:613-616.
12. Dennis F, Landers DF, Gary EH, Wong KC, Fox IJ: Blood transfusion-induced immunomodulation. Anesth Analg 1996;82:187-204.
13. Francis DMA: Relationship between blood transfusion and tumor behaviour. Br J Surg 1991;78:1420-1428.
14. Jacobi K, Walther A, Kühn R, Dworak O, Neidhardt B, Rugheimer E: Möglichkeiten und Grenzen der intraoperativen maschinellen Autotransfusion (MAT) bei radikalen Prostatektomien. Anaesthesist 1997;46:101-107.
15. Neuhof H: Eicosanoids in trauma and traumatic shock: in: Schlag G, Redl H: Pathophysiology of Shock, Sepsis and Organ Failure. Berlin, Springer, 1993, pp 79-91.
16. Watkins WD, Peterson MB, Fletcher JR: Prostaglandins in clinical practice. New York, Raven Press, 1989, pp 183-194.
17. Cirino M, Morton H, MacDonald C, Hadden J, Ford-Hutchinson AW: Thromboxane A2 and prostaglandin endoperoxide analogue effects on porcine renal blood flow. Am J Physiol 1990;258:F109-F114.
18. Siegel JH: Eicosanoids, cytokines and altered metabolic control in the evolution of the post-traumatic host defence failure syndromes: Adult respiratory distress syndrome and multiple organ failure syndrome; in Faist E, Meakins J, Schildberg FW (eds): Host Defence Dysfunction in Trauma, Shock and Sepsis. Berlin, Springer, 1993, pp 199-219.
19. Matera G, Cook JA, Henningar RA, Tempel GE, Wise WC, Oglesby TD, Halushka PV: Beneficial effects of a 5-lipoxygenase inhibitor in endotoxic shock in the rat. J Pharmacol Exp Ther 1988;247:363-371.
20. Cook JA, Wise WC, Halushka PV: Protective effect of a selective leukotriene antagonist in endotoxemia in the rat. J Pharmacol Exp Ther 1985;235:470-474.
21. Suchner U, Senftleben U: Effekte von mehrfach ungesättigten Fettsäuren auf den Immunstatus: Bedeutung als Struktur-und Mediatorbausteine. Infusionsther Transfusionsmed 1994;21:59-70.
22. Suchner U, Senftleben U: Immune modulation by polyunsaturated fatty acids during nutritional therapy: Interactions with synthesis and effects of eicosanoids. Infusionsther Transfusionsmed 1994;21:167-182.
23. Brunson ME, Alexander JW: Mechanisms of tranfusion-induced immunosuppression. Transfusion 1990;30:651-658.
24. Kalechman Y, Gafter U, Sobelman D, Sredni B: The effect of a ,single whole-blood transfusion on cytokine secretion. J Clin Immunol 1990;10:99-105.
25. Waymack JP, Gallon L, Barcelli U, Trocki O, Alexander JW: Effect of blood tranfusions on immune function - III Alterations in macrophage araehidonic acid metabolism. Arch Surg 1987;122:56-60.
26. Lenhard V, Gemsa D, Opelz G: Tranfusion-induced release of prostaglandin E2 and its role in the activation of T-suppressor cells. Transplant Proc 1985;17:2380-2382.
27. Kinsella JE, Lokesh B, Broughton S, Whelan J: Dietary polyunsaturated fatty acids and eicosanoids: Potential effects on the modulation of inflammatory and immune cells. An overview. Nutrition 1990;6:24-44.
28. Grunenberg R, Krueger J: Analysis of cytokine profiles of stored CPDA-1 whole Wood. Infusionsther Transfusionsmed 1995;22:292-294.
29. Hwang D: Essential fatty acids and immune response. FASEB J 1989;3:2052-2061.
30. Kinsella JE, Lokesh B: Dietary lipids, eicosanoids, and the immune system. Crit Care Med 1990;18:S94-S113.